Name: Tetratherix (TTX) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

TTX

Pharmaceuticals, Biotechnology & Life Sciences

Tetratherix

Short interest: 0.02%; +0.02 pp 30d; as of 13 Oct 2026
Reported shorts: 6.3K
Shares on issue: 29.496M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Tetratherix

Company profile →

Tetratherix (ASX:TTX) has 0.02% of its shares on issue reported as short positions as of 13 Oct 2026, or about 6,286 shares. Over the past 30 days that figure has been broadly flat, and over 7 days it has been broadly flat. TTX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 42, 2026.

Strategy fit

How each stock picker strategy reads TTX today

Zanger BreakoutNot a candidate
CAN SLIMWatchScore 23rank 965 of 1537
Minervini Trend TemplateWatchScore 34rank 482 of 1691
Crowded-Short BreakoutNot a candidate
Quality compoundersWatchScore 15rank 1041 of 1671

Prices to 19 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

TTX fundamentals

In the year to 30 Jun 2026, Tetratherix (ASX:TTX) recorded revenue of A$918.2K and a net loss after tax of A$9.3M. A year earlier it recorded a net loss after tax of A$9.4M. Net margin −1,015.1%, return on equity −31.1% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →